Research programme: cancer therapeutics - China Sky One Medical

Drug Profile

Research programme: cancer therapeutics - China Sky One Medical

Alternative Names: Endostatin - China Sky One Medical; Endothelin-1

Latest Information Update: 09 Mar 2011

Price : $50

At a glance

  • Originator Harbin Medical University
  • Developer China Sky One Medical
  • Class Proteins
  • Mechanism of Action Angiogenesis inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Preclinical Cancer

Most Recent Events

  • 09 Mar 2011 Preclinical development is ongoing in China
  • 08 Sep 2008 Preclinical trials in Cancer in China (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top